Search

Your search keyword '"Rueda B"' showing total 76 results

Search Constraints

Start Over You searched for: Author "Rueda B" Remove constraint Author: "Rueda B" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
76 results on '"Rueda B"'

Search Results

1. The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database

2. NOVEDADES EN EAS:FROM BENCH TO BEDSIDE.

3. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

4. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

5. Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases

6. Assessment of the worldwide burden of critical illness: The Intensive Care Over Nations (ICON) audit

7. Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes

9. Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes

10. Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes

12. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.

13. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators.

14. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

15. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

16. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population

17. Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

18. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

19. The functional polymorphism 844 A>G in FcalphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility

20. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

21. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

22. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

23. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population

24. Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

25. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

26. The functional polymorphism 844 A>G in FcalphaRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility

27. Corrigendum: Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

28. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

29. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population

30. Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.

31. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort.

32. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.

33. A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators

34. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis

35. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.

36. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

37. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).

38. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.

39. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.

40. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.

41. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

42. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).

43. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.

44. BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians.

45. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.

46. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus.

47. Functional variants of Fc gamma receptor (FCGR2A) and FCGR3A are not associated with susceptibility to systemic sclerosis in a large European Study (EUSTAR).

48. The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.

49. Genética de la esclerodermia

50. Studying the influence of PTPN22 gene in systemic scleroderma

Catalog

Books, media, physical & digital resources